The analysis of the expression levels of the direct targets of RUNX2 identified ETS1, a transcriptional regulator of lung cancer that appears in the NSCLC regulatory network and is a coregulator of a significant number of TFs identified in the coexpression networks, which are associated with lung cancer. This evidence concerns the gene RUNX2 and lung carcinoma.